Skip to content

Antireflux surgery in pediatric GERD patients.

Laparoscopic fundoplication for gastroesophageal reflux disease: A prospective study on reflux control and gastroesophageal motility.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26312
Enrollment
55
Registered
2011-05-31
Start date
2011-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux, antireflux surgery, fundoplication, children

Interventions

Laparoscopic Thal or Nissen fundoplication.

Sponsors

University Medical Center Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children (0-18yrs) with severe GERD: 1. Referred for antireflux surgery by a pediatrician/pediatric gastroenterologist and; 2. Proven therapy-resistant or recurrent pathological gastroesophageal reflux and; 3. In whom written informed consent can be obtained (Children >12yrs old and normally developed informed consent obtained from parents/guardians and child; Children <12 yrs and/or neurologically impaired informed consent obtained from parents/guardian).

Exclusion criteria

Exclusion criteria: 1. Inability to undergo investigation; 2. Prior esophageal and/or gastric surgery, except gastrostoma.

Design outcomes

Primary

MeasureTime frame
Percentage of failed antireflux procedures: 1. Percentage time pH 4%); 2. Number of reflux episodes/24hr (> 9); 3. Number of reflux episodes longer than 5 minutes (> 4); 4. Symptom scores (symptoms &#8805; moderate-severe and/or daily-weekly); Gastroesophageal function/motility: 1. Lower esophageal sphincter relaxation (% complete relaxation); 2. Percentage peristaltic contractions esophagus (%); 3. Contractions proximal/mid/distal esophagus (mmHg); 4. Gastric half-emptying time (min) as measured by 13C octanoic acid breath test; 5. Maximal proximal gastric adaptive relaxation (ml) as measured by 3D-US. Success is defined as: 1. Complete symptom relief and normalised pH metry; 2. Complete symptom relief and near-normal pH metry; 3. Normalized pH metry and significant improvement of reflux symptoms (complaints less than mild/monthly).

Secondary

MeasureTime frame
Health-related quality of life.

Contacts

Public ContactF.A. Mauritz

PO Box 85500

f.a.mauritz@umcutrecht.nl+31 (0)88 7554004

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)